Isis 113715, a novel PTP-1B antisense inhibitor, improves glycemic control and dyslipidemia and increases adiponectin levels in T2DM subjects uncontrolled on stable sulfonylurea therapy

Category Primary study
JournalDiabetes
Year 2010
This article has no abstract
Epistemonikos ID: 3f28d8cbdc7a38cb6e8d03f97a19371c403105fd
First added on: Feb 06, 2025